Non-invasive management of peripheral arterial disease.

File Description SizeFormat 
non invasive mx of pad - corrected proofs.pdfAccepted version188.24 kBAdobe PDFView/Open
Title: Non-invasive management of peripheral arterial disease.
Authors: Williams, KJ
Babber, A
Ravikumar, R
Davies, AH
Item Type: Journal Article
Abstract: BACKGROUND: Peripheral arterial disease (PAD) is common and symptoms can be debilitating and lethal. Risk management, exercise, radiological and surgical intervention are all valuable therapies, but morbidity and mortality rates from this disease are increasing. Circulatory enhancement can be achieved using simple medical electronic devices, with claims of minimal adverse side effects. The evidence for these is variable, prompting a review of the available literature. METHODS: Embase and Medline were interrogated for full text articles in humans and written in English. Any external medical devices used in the management of peripheral arterial disease were included if they had objective outcome data. RESULTS: Thirty-one papers met inclusion criteria, but protocols were heterogenous. The medical devices reported were intermittent pneumatic compression (IPC), electronic nerve (NMES) or muscle stimulators (EMS), and galvanic electrical dressings. In patients with intermittent claudication, IPC devices increase popliteal artery velocity (49-70 %) and flow (49-84 %). Gastrocnemius EMS increased superficial femoral artery flow by 140 %. Over 4.5-6 months IPC increased intermittent claudication distance (ICD) (97-150 %) and absolute walking distance (AWD) (84-112 %), with an associated increase in quality of life. NMES of the calf increased ICD and AWD by 82 % and 61-150 % at 4 weeks, and 26 % and 34 % at 8 weeks. In patients with critical limb ischaemia IPC reduced rest pain in 40-100 % and was associated with ulcer healing rates of 26 %. IPC had an early limb salvage rate of 58-83 % at 1-3 months, and 58-94 % at 1.5-3.5 years. No studies have reported the use of EMS or NMES in the management of CLI. CONCLUSION: There is evidence to support the use of IPC in the management of claudication and CLI. There is a building body of literature to support the use of electrical stimulators in PAD, but this is low level to date. Devices may be of special benefit to those with limited exercise capacity, and in non-reconstructable critical limb ischaemia. Galvanic stimulation is not recommended.
Issue Date: 17-Sep-2016
Date of Acceptance: 1-Sep-2016
URI: http://hdl.handle.net/10044/1/42836
DOI: http://dx.doi.org/10.1007/5584_2016_129
ISSN: 0065-2598
Publisher: Kluwer
Start Page: 387
End Page: 406
Journal / Book Title: Advances in Experimental Medicine and Biology
Volume: 906
Copyright Statement: © 2016 Springer International Publishing Switzerland. The final publication is available at Springer via http://dx.doi.org/10.1007/5584_2016_129
Keywords: Chronic venous disease
DVT
Electrical stimulation
NMES
Pulmonary embolism
Thrombosis
General & Internal Medicine
11 Medical And Health Sciences
Publication Status: Published
Appears in Collections:Division of Surgery
Faculty of Medicine



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Creative Commonsx